Company news

Cabaletta Bio, Inc. news in 2022

Cabaletta Bio, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Cabaletta Bio Announces $35 Million Offering

December 7, 2022

Cabaletta Bio to Present at the 5th Annual Evercore ISI HealthCONx Conference

November 21, 2022

Cabaletta Bio Reports Third Quarter 2022 Financial Results and Provides Business Update

November 9, 2022

IASO Biotherapeutics and Cabaletta Bio Announce Exclusive Worldwide License Agreement for Clinically Validated CD19 Binder

October 10, 2022

Cabaletta Bio Announces CABA-201, a Newly Designed CD19-Targeting CAR T Cell Therapy Engineered to Address a Broad Range of Autoimmune Diseases

October 10, 2022

Cabaletta Bio to Present at the 29th Annual Congress of the European Society of Gene & Cell Therapy

October 5, 2022

Cabaletta Bio to Present at the Chardan 6th Annual Genetic Medicines Conference

September 25, 2022

Cabaletta Bio Presents New Interim Data from the DesCAARTes™ Phase 1 Trial at the 31st EADV Congress

September 9, 2022

Cabaletta Bio to Present Data at the 31st EADV Congress and Provides Update on DesCAARTes™ Trial

August 28, 2022

Cabaletta Bio Reports Second Quarter 2022 Financial Results and Provides Business Update

August 10, 2022

Cabaletta Bio Presents Updated Interim DesCAARTes™ Trial Phase 1 Data at the ASGCT 25th Annual Meeting

May 17, 2022

Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference

May 16, 2022

Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update

May 11, 2022

Cabaletta Bio to Present DSG3-CAART Clinical Data and MuSK-CAART Preclinical Data at Upcoming Scientific Meetings in May

May 1, 2022

Cabaletta Bio to Present at the 21st Annual Needham Virtual Healthcare Conference

April 5, 2022

Cabaletta Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

March 16, 2022

U.S. Food and Drug Administration Grants Cabaletta Bio Fast Track Designation for MuSK-CAART

February 28, 2022

Cabaletta Bio to Participate in the Cowen Virtual 42nd Annual Health Care Conference

February 27, 2022

Cabaletta Bio Strengthens Executive Leadership Team with Promotions of Gwendolyn Binder, Ph.D. to President of Science and Technology and Arun Das, M.D. to Chief Business Officer

January 10, 2022

Cabaletta Bio to Present at the 40th Annual J.P. Morgan Healthcare Conference

January 9, 2022

Cabaletta Bio to Present at the H.C. Wainwright BioConnect Conference

January 2, 2022

Decks in 2022